MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

IOVA is expected to report earnings to fall 7.00% to -24 cents per share on May 13

Iovance Biotherapeutics IOVA Stock Earnings Reports
Q1'25
Est.
$-0.24
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.42
The last earnings report on February 27 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 9.06M shares outstanding, the current market capitalization sits at 1.07B.
View a ticker or compare two or three
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biotechnological products for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com